Viewing Study NCT00019656

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-05-19 @ 5:01 PM
Study NCT ID: NCT00019656
Status: COMPLETED
Last Update Posted: 2015-04-29
First Post: 2001-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Neoplasms View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV chronic lymphocytic leukemia View
None refractory chronic lymphocytic leukemia View
None unspecified adult solid tumor, protocol specific View
None previously treated myelodysplastic syndromes View
None de novo myelodysplastic syndromes View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent adult Hodgkin lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent mantle cell lymphoma View
None secondary myelodysplastic syndromes View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult Burkitt lymphoma View
None stage IV adult Hodgkin lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV mantle cell lymphoma View
None chronic myelomonocytic leukemia View
None atypical chronic myeloid leukemia, BCR-ABL1 negative View
None myelodysplastic/myeloproliferative neoplasm, unclassifiable View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View